AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
AAPL   372.69 (-0.31%)
MSFT   208.25 (-1.16%)
FB   240.86 (+0.24%)
GOOGL   1,489.92 (-0.65%)
AMZN   3,000.12 (-1.86%)
NVDA   394.87 (+0.33%)
CGC   16.50 (-2.60%)
BABA   236.51 (-1.45%)
MU   49.09 (-3.59%)
GE   6.76 (-3.43%)
TSLA   1,389.86 (+1.33%)
AMD   52.93 (-0.88%)
T   30.32 (-0.56%)
ACB   12.42 (+1.97%)
F   6.12 (-1.13%)
GILD   76.42 (-0.44%)
DIS   113.63 (-0.69%)
BAC   23.01 (-2.75%)
NFLX   493.16 (-0.13%)
BA   178.88 (-4.81%)
Log in

NASDAQ:LJPCLa Jolla Pharmaceutical SEC Filings & 10K Form

$4.58
+0.14 (+3.15 %)
(As of 07/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$4.32
Now: $4.58▼
$4.64
50-Day Range
$4.39
MA: $5.38▼
$7.22
52-Week Range
$2.30
Now: $4.58▼
$11.41
Volume359,300 shs
Average Volume922,195 shs
Market Capitalization$125.03 million
P/E RatioN/A
Dividend YieldN/A
Beta2.53

SEC Filings

La Jolla Pharmaceutical (NASDAQ:LJPC) SEC Filings

DateFilerForm TypeView
07/01/2020
6:08 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:30 AM		La Jolla Pharmaceutical (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form SC TO-T
06/25/2020
8:58 PM		La Jolla Pharmaceutical (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form SC 13D/A
06/24/2020
6:48 AM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2020
6:46 AM		La Jolla Pharmaceutical (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form SC TO-C
06/22/2020
4:17 PM		La Jolla Pharmaceutical (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form SC 13D
06/22/2020
4:16 PM		La Jolla Pharmaceutical (Reporting)
TETRAPHASE PHARMACEUTICALS INC (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:13 PM		La Jolla Pharmaceutical (Reporting)
TETRAPHASE PHARMACEUTICALS INC (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/22/2020
7:52 AM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2020
7:50 AM		La Jolla Pharmaceutical (Filed by)
TETRAPHASE PHARMACEUTICALS INC (Subject)
Form SC TO-C
06/17/2020
5:26 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
5:04 AM		La Jolla Pharmaceutical (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D/A
06/04/2020
5:26 PM		Hearne Michael S (Reporting)
La Jolla Pharmaceutical (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
7:26 AM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
5:04 AM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
3:02 PM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/04/2020
7:12 AM		La Jolla Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/02/2020
5:08 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
5:08 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
5:08 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
7:15 AM		La Jolla Pharmaceutical (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2020
12:42 PM		La Jolla Pharmaceutical (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
02/13/2020
4:24 PM		Broadfin Capital, LLC (Filed by)
La Jolla Pharmaceutical (Subject)
Form SC 13G/A
02/13/2020
7:32 AM		La Jolla Pharmaceutical (Subject)
SECTORAL ASSET MANAGEMENT INC (Filed by)
Form SC 13G/A
02/07/2020
9:06 AM		JENNISON ASSOCIATES LLC (Filed by)
La Jolla Pharmaceutical (Subject)
Form SC 13G/A
02/05/2020
11:16 AM		BlackRock Inc. (Filed by)
La Jolla Pharmaceutical (Subject)
Form SC 13G/A
01/17/2020
3:14 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:14 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2020
3:13 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
5:02 AM		La Jolla Pharmaceutical (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D/A
01/13/2020
4:59 PM		La Jolla Pharmaceutical (Issuer)
TANG CAPITAL MANAGEMENT LLC (Reporting)
TANG CAPITAL PARTNERS LP (Reporting)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
3:19 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
3:18 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
3:18 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
3:17 PM		Johnson Craig A (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
3:17 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2020
7:57 AM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2019
3:10 PM		La Jolla Pharmaceutical (Issuer)
Rosen Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:09 PM		La Jolla Pharmaceutical (Issuer)
RAMSAY DAVID A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:09 PM		Douglass Laura L. (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:08 PM		Johnson Craig A (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:05 PM		La Jolla Pharmaceutical (Issuer)
TANG KEVIN C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:03 PM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
8:43 AM		FMR LLC (Filed by)
La Jolla Pharmaceutical (Subject)
Form SC 13G/A
12/06/2019
4:01 PM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
3:28 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
3:27 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
3:27 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2019
3:01 PM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
3:12 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:12 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:11 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2019
3:11 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:06 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:05 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
3:05 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2019
7:03 PM		La Jolla Pharmaceutical (Issuer)
RAMSAY DAVID A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2019
3:47 PM		La Jolla Pharmaceutical (Issuer)
RAMSAY DAVID A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/17/2019
4:42 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:41 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:41 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2019
4:40 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2019
3:18 PM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
4:06 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:05 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:05 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
4:04 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2019
3:17 PM		La Jolla Pharmaceutical (Filer)
Form DEF 14A
09/16/2019
6:24 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
6:24 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
6:24 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
6:23 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
3:13 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
3:12 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
3:12 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2019
3:12 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:51 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:51 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:50 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
3:50 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
7:30 AM		La Jolla Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
3:59 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:59 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:59 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2019
3:59 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
7:11 AM		La Jolla Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/17/2019
4:11 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
4:10 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
4:10 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2019
4:10 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
5:12 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
5:11 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
5:11 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2019
5:11 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:45 PM		La Jolla Pharmaceutical (Issuer)
Wellinghoff Darryl (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:44 PM		La Jolla Pharmaceutical (Issuer)
MULROY DENNIS (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:44 PM		La Jolla Pharmaceutical (Issuer)
Rolke James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:44 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
8:28 AM		La Jolla Pharmaceutical (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
06/03/2019
6:27 PM		Chawla Lakhmir S (Reporting)
La Jolla Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.